Clinical Study on Evaluating the Safety and Effectiveness of BCMA-GPRC5D CAR-T in Patients With Relapsed/Refractory Multiple Myeloma Who Have Received Third-line or Above Treatment
Clinical trial NCT07195617 · WITHDRAWN
Trial details
- NCT number
- NCT07195617
- Sponsor
- Guangzhou Bio-gene Technology Co., Ltd
- Status
- WITHDRAWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-10
- Primary completion
- 2027-11-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.